Finance

Lists
SUVEN:NSE
Suven Life Sciences Ltd
304,85 INR
+1,53%
(+4,60) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SUVEN...
Open
304,00 INR
High
308,85 INR
Low
298,10 INR
Mkt. cap
85,83 მლრდ.
Avg. vol.
638,84 ათ.
Volume
527,97 ათ.
52-wk high
403,35 INR
52-wk low
124,11 INR
EPS
-14,77 INR
Shares outstanding
127,28 მლნ.
No. of employees
142
Open
304,00 INR
High
308,85 INR
Low
298,10 INR
Mkt. cap
85,83 მლრდ.
Avg. vol.
638,84 ათ.
Volume
527,97 ათ.
52-wk high
403,35 INR
52-wk low
124,11 INR
EPS
-14,77 INR
Shares outstanding
127,28 მლნ.
No. of employees
142
News stories
From web sources and news partners
About Suven Life Sciences Ltd
CEOვენკატესვარლუ ჯასტი
Employees142
Founded1989
Headquarters-
SectorHealth care
Websitesuven.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
9,19 მლნ.
28,09 მლნ.
15,20 მლნ.
35,66 მლნ.
Cost of goods sold
-
-
6,32 მლნ.
-
Cost of revenue
-
-
6,32 მლნ.
-
Research and development expenses
703,21 მლნ.
940,47 მლნ.
423,31 მლნ.
1,24 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
60,76 მლნ.
62,68 მლნ.
139,60 მლნ.
72,82 მლნ.
Operating expense
820,07 მლნ.
1,08 მლრდ.
527,25 მლნ.
1,38 მლრდ.
Total operating expenses
820,07 მლნ.
1,08 მლრდ.
533,57 მლნ.
1,38 მლრდ.
Operating income
-810,88 მლნ.
-1,05 მლრდ.
-518,36 მლნ.
-1,35 მლრდ.
Other non operating income
37,78 მლნ.
27,74 მლნ.
-71,44 მლნ.
75,24 მლნ.
EBT including unusual items
-773,10 მლნ.
-1,02 მლრდ.
-455,96 მლნ.
-1,28 მლრდ.
EBT excluding unusual items
-773,10 მლნ.
-1,02 მლრდ.
-551,33 მლნ.
-1,28 მლრდ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
42,92 მლნ.
58,44 მლნ.
-51,49 მლნ.
49,56 მლნ.
Net income
-773,10 მლნ.
-1,02 მლრდ.
-455,96 მლნ.
-1,28 მლრდ.
Net profit margin
-8 410,56%
-3 628,79%
-2 999,51%
-3 578,73%
Earnings per share
-
-
-
-
Interest and investment income
-
-
42,48 მლნ.
-
Interest expense
-
-
-1,58 მლნ.
-4,76 მლნ.
Net interest expenses
-
-
40,90 მლნ.
-4,76 მლნ.
Depreciation and amortization charges
13,17 მლნ.
13,46 მლნ.
15,82 მლნ.
21,55 მლნ.
EBITDA
-797,45 მლნ.
-1,03 მლრდ.
-505,35 მლნ.
-1,33 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები